drugset
drugset / Trial / NCT04505514

Single Dose Intravenous Iron Isomaltoside in Combination With Oral Iron vs Oral Iron Monotherapy in Patients With Anemia After Postpartum Haemorrhage

NCT04505514 ↗

Phase 4 Unknown 60 enrolled University of Malaya
RandomizedParallel-groupSingle-blindTreatment

Summary

The investigator's study is going to compare effectiveness of single dose intravenous iron in combination with oral iron versus oral iron monotherapy in correcting haemoglobin deficit, replenishing iron stores and improving clinical symptoms in women with post-partum anaemia after postpartum hemorrhage without increasing the rate of adverse outcomes.

Timeline

Start
2020-08-01
Primary completion
2022-10-31
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron isomaltoside 1000 Unknown 1000 mg Intravenous
Background Iberet-Folic-500 Unknown — —

Indications

anemia